AneurysmFlow
Cerebral aneurysm flow quantification
AneurysmFlow
Cerebral aneurysm flow quantification
Assessing impact of embolization devices, like flow diverters, on blood flow right after deployment is crucial. AneurysmFlow is designed to provide relevant information based on quantification of blood flow changes.
Clinical image gallery
Features
Enhances decision making
AneurysmFlow automatically measures the following parameters within the region of interest defined: time averaged arterial flow, time and spatially averaged projected aneurysm flow, and Mean Aneurysm Flow Amplitude (MAFA) ratio. Users can also view the following information as graphs: time dependent arterial flow and time dependent, spatially averaged projected aneurysm flow.
New information with Mean Aneurysm Flow Amplitude ratio
The Mean Aneurysm Flow Amplitude (MAFA) ratio represents the change in blood flow in the aneurysm after flow diverter deployment. The MAFA ratio is derived by comparing the average projected velocity of the blood flow in the aneurysm before and after flow diverter deployment. This ratio is corrected for average velocity change of the blood flow in the primary feeding vessel to the aneurysm.
Relevant information about blood vessel flow
Flow diverters are being increasingly used to treat cerebral aneurysms, but flow diversion procedures remain challenging. Only 76% of all aneurysm flow diversion cases result in thrombosis after 6 month follow-up,¹ which poses a risk to the patient. Several authors have shown that the flow pattern inside aneurysms is considered one of the parameters that can be used to predict rupture and clotting.²,³
AneurysmFlow is the first tool that visualizes and quantifies flow changes in the parent vessel and aneurysm before and after flow diverter deployment. It also provides a unique metric – the Mean Aneurysm Flow Amplitude (MAFA) ratio.
Related products
- This X-ray acquisition technique generates a complete high-resolution 3D visualization of cerebral, cardiac, abdominal or peripheral vasculature from a single rotational angiography run – all controlled via the touch screen at the table. This can improve visibility of tortuous or complex anatomy that may not be seen on a 2D or DSA image.
- SmartCT Roadmap facilitates complex interventions by providing live 3D image guidance that can be segmented to emphasize target vessel and lesions, aiding guidewire and catheter navigation through complex vessel structures. All controlled via the touch screen at the table.
- SmartCT Soft Tissue offers a Cone Beam CT (CBCT) acquisition technique augmented with step-by-step guidance, Advanced 3D visualization and measurement tools all accessible on the touch screen module at table side. To support you in acquiring CBCT images first-time right [1] and to streamline your workflow, you are guided through key steps. Once the CBCT scan is successfully performed, the acquired 3D image is automatically displayed in the SmartCT 3D visualization tool with the adequate rendering settings and the 3D measurement tools tailored for the selected 3D protocol.
- SmartCT Vaso enables high-contrast and high-resolution imaging of cerebral vasculature based on a 3D rotational scan and an intra-arterial contrast injection. This technique enhances the visualization of endovascular stents, flow diverters, or other devices, as well as vessel morphology down to the perforator level.
Disclaimer
1. Brinjikji W, Murad MH, Lanzino G. et al. Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke. 2013;44:442–447.
2. Augsburger L, et al. Methodologies to assess blood flow in cerebral aneurysms: Current state of research and perspectives. J Neurorad. 2009;36:270–277.
3. Sforza DM, Putman CM, Cebral JR. Hemodynamics of Cerebral Aneurysms. Annu Rev Fluid Mech. 2009; 41:91–107.
This product is based on open source software.